A Boston-based company reports exciting results on a new approach to treat genetic diseases. Phenylketonuria (PKU) is a genetic metabolic disorder…
When you choose to publish with PLOS, your research makes an impact. Make your work accessible to all, without restrictions, and accelerate scientific discovery with options like preprints and published peer review that make your work more Open.
PLOS is a nonprofit Open Access publisher, innovator and advocacy organization dedicated to accelerating progress in science and medicine by leading a transformation in research communication.
A Boston-based company reports exciting results on a new approach to treat genetic diseases. Phenylketonuria (PKU) is a genetic metabolic disorder…